The geographic distance to facilities offering breast magnetic resonance imaging (MRI) or ultrasound is further than to those offering mammography, according to a study published online Aug. 12 in the American Journal of Preventive Medicine.
Newly published research in The Lancet Oncology lays the foundation for many patients with head and neck cancers to be treated with tailored therapies that are less invasive and to avoid major, potentially debilitating surgeries. This step toward a major shift in practice is prompted by new imaging guidelines established in the study. As a result, imaging techniques like CT, PET and MRI can be better utilized to determine the aggressiveness of the cancer and point patients toward radiation therapy instead of surgery in certain cases.
A new imaging technique developed at Memorial Sloan Kettering Cancer Center (MSK) shows promise for detecting deadly forms of lung cancer and prostate cancer. The technology uses a radioactive particle that binds to a ligand (molecule) on cancer cells called DLL3, making the cells more visible on PET scans.
New Corewell Health research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years. Knowing this could potentially help doctors determine if treatment is needed up front vs. using a method called active surveillance where the disease is closely monitored over time.
A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the potential to spur advances in the treatment of many brain diseases.
